首页> 外文期刊>Molecular human reproduction. >Changes in gene expression during the early to mid-luteal (receptive phase) transition in human endometrium detected by high-density microarray screening.
【24h】

Changes in gene expression during the early to mid-luteal (receptive phase) transition in human endometrium detected by high-density microarray screening.

机译:通过高密度微阵列筛选检测到的人类子宫内膜在黄体早期到中期(接受期)过渡过程中基因表达的变化。

获取原文
获取原文并翻译 | 示例
           

摘要

High density cDNA microarray screening was used to determine changes in gene expression occurring during the transition between the early luteal (prereceptive) and mid-luteal (receptive) phases in human endometrium. Of approximately 12 000 genes profiled, 693 (5.8%) displayed >2-fold differences in relative levels of expression between these stages. Of these, 370 genes (3.1%) displayed decreases ranging from 2- to >100-fold while 323 genes (2.7%) displayed increases ranging from 2- to >45-fold. Many genes correspond to mRNAs encoding proteins previously shown to change in a similar manner between the proliferative and mid-luteal phases, serving as one validation of the microarray screening results. In addition, novel genes were identified. Genes encoding cell surface receptors, adhesion and extracellular matrix proteins and growth factors accounted for 20% of the changes. Several genes were studied further by Northern blot analyses. These results confirmed that claudin-4/Clostridium perfringens enterotoxin (CPE) receptor and osteopontin (OPN) mRNA increased approximately 4- and 12-fold respectively, while betaig-H3 (BIGH3) decreased >80% during the early to mid-luteal transition. Immunostaining also revealed strong specific staining for claudin-4/CPE, EP(1) and prostaglandin receptor in epithelia, and leukotriene B4 receptor in both epithelia and stroma, at the mid-luteal stage. Collectively, these studies identify multiple new candidate markers that may be used to predict the receptive phase in humans. Some of these gene products, e.g. OPN, may play direct roles in embryo-uterine interactions during the implantation process.
机译:高密度cDNA微阵列筛选用于确定人类子宫内膜的黄体早期(接受)阶段和黄体中期(接受)阶段之间的过渡过程中发生的基因表达变化。在大约12000个基因中,有693个(5.8%)在这些阶段之间的相对表达水平显示出> 2倍的差异。其中,显示的370个基因(3.1%)降低了2到> 100倍,而显示的323个基因(2.7%)升高了2到> 45倍。许多基因对应于编码蛋白质的mRNA,这些蛋白质先前显示出在增殖期和黄体中期之间以相似的方式发生变化,这是对微阵列筛选结果的一种验证。另外,鉴定了新基因。编码细胞表面受体,粘附和细胞外基质蛋白以及生长因子的基因占了20%的变化。通过Northern印迹分析进一步研究了几种基因。这些结果证实了claudin-4 /产气荚膜梭菌肠毒素(CPE)受体和骨桥蛋白(OPN)mRNA分别增加了约4倍和12倍,而贝塔格-H3(BIGH3)在黄体早期至中期过渡期降低了> 80% 。免疫染色还显示,在黄体中期,上皮中claudin-4 / CPE,EP(1)和前列腺素受体以及上皮和间质中的白三烯B4受体均具有很强的特异性染色。这些研究共同确定了多个新的候选标记,可用于预测人类的接受阶段。这些基因产物中的一些例如OPN在植入过程中可能在胚胎与子宫的相互作用中起直接作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号